New Trial Data Shows Dexcom G7 Meaningfully Imp...
Dexcom sponsored CONNECT randomized controlled trial expected to help establish new standard of care for CGM use by people with Type 2 diabetes not using insulin around the world Dexcom...
Why DME Providers Should Offer Continuous Gluco...
Continuous Glucose Monitoring (CGM) is quickly becoming a standard in diabetes management. While Blood Glucose Monitoring (BGM) remains vital, CGM adds continuous data, proactive alerts, and actionable insights that can...
Time-in-Range (TIR): Why It Matters and How CGM...
Diabetes care is evolving beyond A1C alone. Time-in-Range (TIR), the percentage of time a person’s blood glucose stays within a healthy range, is becoming a powerful new metric for tracking...
CGM & BGM – Two Essential Tools in Diabetes Care
Blood Glucose Monitoring (BGM)—often called fingersticks—has been the go-to method for people managing diabetes for decades. It’s simple, accessible, and remains essential in many care plans. In recent years, Continuous...
Why CGM Is the Future of Diabetes Management
For decades, diabetes management has centered around fingerstick blood glucose tests—brief snapshots of a patient’s glucose level. But today, technology is reshaping that reality. Continuous Glucose Monitoring (CGM) is no longer...